Not only preclinical, but also clinical studiesconfirm that NIS, expressed in oncolytic viruses, can be used to accuratelydetermine tumor localization and response to therapy, as well as detectmetastases using deep-tissue nuclear imaging. This evidence concerns the gene SLC5A5 and neoplasm.